Showing posts with label Age-related. Show all posts
Showing posts with label Age-related. Show all posts

Thursday, November 10, 2022

Cholesterol and diabetes drugs may lessen risk of degenerative eye disease of aging


Regular use of drugs to lower cholesterol and control type 2 diabetes may lessen the risk of age related macular degeneration, a degenerative eye disease that is associated with aging. This is a finding from a pooled data analysis of the available evidence, which has been published in the British Journal of Ophthalmology.

The results show that these common drugs are linked to lower prevalence of AMD in European populations.

Wednesday, July 13, 2022

Blinding eye disease is strongly associated with heart disease and stroke

(c) Ophthalmology Retina

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai. This study, published in the July issue of Retina, is the first to demonstrate a link between the disorders.

Wednesday, March 10, 2021

New Study links Alzheimer's disease to Age-related Macular Degeneration

(c) Cells [link below]
Newly published research has revealed a close link between proteins associated with Alzheimer's disease and age-related sight loss. The findings could open the way to new treatments for patients with deteriorating vision and through this study, the scientists believe they could reduce the need for using animals in future research into blinding conditions.

Monday, August 17, 2020

Researchers develop cell injection technique that could help reverse vision loss

University of Toronto Engineering researchers have developed a new method of injecting healthy cells into damaged eyes. The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.

Sunday, April 19, 2020

Study finds link between poor diet and age-related macular degeneration

(c) Univ of Buffalo
Participants who ate a diet high in red and processed meat, fried food, refined grains and high-fat dairy were three times more likely to develop an eye condition that damages the retina and affects a person’s central vision, according to the results of a study conducted at University of Buffalo and published in the journal BMJ Ophthalmology.

The condition is called late-stage age-related macular degeneration (AMD). AMD is an irreversible condition that affects a person’s central vision, taking away their ability to drive, among other common daily activities.

Thursday, April 2, 2020

Embryonic stem cells for treating blindness

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.

Using CRISPR/Cas9 gene editing, they also modified the cells so that they can hide from the immune system to prevent rejection.

Wednesday, March 7, 2018

Muller cells a key cell in preventing age-related vision loss

(c) Duke
Duke researchers have pinpointed a new therapeutic target for macular degeneration. Clinical trials have shown that injection of human umbilical stem cells, or hUTC, into the retina helps preserve and restore vision in macular degeneration patients. However, the underlying mechanisms behind the therapy remain unknown. Their findings show that hUTC treatment preserves the function of a retinal cell called the Müller glia in rats with degenerative vision loss.

Tuesday, March 6, 2018

New Research demonstrates success with Gene Therapy for a form of Inherited Macular Degeneration

(c) UPenn News
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. The work sets the stage for translating the findings into a human therapy for an inherited disease that results in a progressive loss of central vision and which is currently untreatable.

Thursday, March 1, 2018

NEI/NIH launch clinical trial to study AMD progression

(c) NEI / NIH
A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration (AMD). By using the latest technologies to visualize structures within the eye and measure their function, researchers hope to identify biomarkers of disease progression, well before it advances to late-stage disease and causes vision loss.

Tuesday, September 29, 2015

First patient receives potential new treatment for wet age-related macular degeneration (AMD)

A pioneering trial of a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) has commenced at Moorfields Eye Hospital following a successful operation on a patient.

Friday, August 28, 2015

AMD likely to be more in people with deficient vitamin D status

A multi-institutional team reports that vitamin D may play a significant role in eye health, specifically in the possible prevention of age-related macular degeneration, or AMD, among women who are more genetically prone to developing the sight-damaging disease.

In a paper published in JAMA Ophthalmology online, the team found that women who are deficient in vitamin D and have a specific high-risk genotype are 6.7 times more likely to develop AMD than women with sufficient vitamin D status and no high risk genotype.

Thursday, August 20, 2015

Amniotic membrane derived stem cell transplants show benefit in retinal diseases

(c) Cell Transplantation
A team of researchers at the CHA University in South Korea has successfully transplanted mesenchymal stromal cells (MSCs) derived from human amniotic membranes of the placenta (AMSCs) into laboratory mice modeled with oxygen-induced retinopathy, which is used to simulate many retinal diseases. The treatment aimed at suppressing abnormal angiogenesis (blood vessel growth) which is recognized as the cause of many eye diseases, such as diabetic retinopathy and age-related macular degeneration. The researchers reported that the AMSCs successfully migrated to the retinas of the test animals and, because of the growth factors secreted by the cells, were able to suppress retinal neovascularization.

Wednesday, June 24, 2015

Vitamin A may harm patients with Stargardt and possibly macular degeneration

An Oxford University study has found that reducing the tendency of vitamin A to form toxic clumps could slow down retinal degenerative diseases such as Stargardt disease, a condition that leads to blindness in children and young adults, and in age-related macular degeneration.

Wednesday, April 15, 2015

Autologous choroidal transplantation may lead to successful results in select AMD cases


Autologous choroidal transplantation may lead to successful outcomes in select patients with age-related macular degeneration who are refractory to anti-VEGF therapy.

Advancements in Retinal Detachment Research Pave the Road to Better Visual Recovery

Editor's notes:

To read more about what is Retinal Detachment, how is it caused, what are the symptoms, and what are the suggested things to do, click here.

Retinal detachment was the first retinal pathology that could be managed with a surgical intervention. Dr Jules Gonin (pictured on the left - credit) came up with a solution to treat this condition. Before that, all patients with retinal detachment were doomed to blindness. His work from 1902 to 1921, when he recognized that a retinal break was the cause of a retinal detachment - and not a consequence as was largely believed those days - helped kickstart the specialty of retinal disease management. Though his technique, referred to as "ignipuncture", is now obsolete, his pioneering work laid the important foundation. Though his work did not gain recognition for quite some time, and was even opposed by many, he finally got his due in 1929 at the International Ophthalmology Congress in Amsterdam. Since then, his legacy has lived on in the eye hospital in Lausanne that bears his name, in the Gonin Medal awarded by the International Council of Ophthalmology, the Club Jules Gonin, and in a street named after his, the very street that he used to walk from home to the hospital every day.


Tuesday, April 14, 2015

Wednesday, January 28, 2015

Is Avastin better than Lucentis for AMD?

A group of researchers from China have evaluated randomized controlled clinical trials from around the world to study the efficacy and safety of Avastintm (bevacizumab) versus Lucentistm (ranibizumab) in wet (neovascular) age-related macular degeneration (AMD).

Monday, January 19, 2015

AMD may be triggered by tiny mineral deposits in retina

Scientists from the University of Maryland School of Medicine have found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration (AMD). This is the first time these mineral deposits have been implicated in the disease, which affects more than 10 million Americans.

Sunday, January 4, 2015

Nanosecond laser therapy reverses pathologic & molecular changes in age-related macular degeneration without retinal damage

from news.com.au


A study demonstrates the capacity of nanosecond laser treatment to reduce drusen and thin basement membrane (BM) while maintaining retinal structure in patients with age-related macular degeneration (AMD).



HIV/AIDS drugs that are FDA approved could treat age-related macular degeneration

from washington.edu
A study published in the journal Science by an international group of scientists, led by the laboratory of Dr. Jayakrishna Ambati, professor and vice chair of the Department of Ophthalmology & Visual Sciences at the University of Kentucky, reports that HIV/AIDS drugs that have been used for the last 30 years could be repurposed to treat age-related macular degeneration (AMD), as well as other inflammatory disorders, because of a previously undiscovered intrinsic and inflammatory activity those drugs possess.